• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SELECT MEDICAL HOLDINGS CORPORATION APPOINTS THOMAS P. MULLIN AS CHIEF EXECUTIVE OFFICER AND ANNOUNCES OTHER CHANGES INVOLVING LONG-TENURED LEADERS

    9/2/25 4:10:00 PM ET
    $SEM
    Hospital/Nursing Management
    Health Care
    Get the next $SEM alert in real time by email

    MECHANICSBURG, Pa., Sept. 2, 2025 /PRNewswire/ -- Select Medical Holdings Corporation ("Select Medical") (NYSE:SEM) today announced the appointment of Thomas P. Mullin as its chief executive officer.  David S. Chernow, who has held the position since 2014, has been appointed vice chairman of the board.  John A. Saich, who most recently held the position of co-president, will serve as the company's sole president.  John F. Duggan has been appointed executive vice president, general counsel and secretary.  The appointments are effective immediately.

    Mr. Mullin joined Select Medical in 2008, most recently serving as co-president overseeing 140 critical illness recovery and inpatient rehabilitation hospitals and the expansive growth of both divisions nationwide.  Over his 17 years with the company, Mr. Mullin has held executive leadership roles of increasing responsibility including executive vice president from 2020-2023, president of specialty hospitals from 2018-2020, and chief operating officer of specialty hospitals from 2016-2018.  Prior to his divisional appointments, Mr. Mullin held a variety of leadership positions in the Critical Illness Recovery Hospital Division, including senior vice president of business and market development, and regional vice president.  Earlier in his Select Medical career, Mr. Mullin held operational positions at the hospital level in the division.

    Mr. Chernow has been appointed vice chairman of the board after serving as the company's chief executive officer since 2014.  Previously, he served as president and chief executive officer from 2014-2023 and as president and chief strategy officer from 2010-2014.  Prior to Mr. Chernow's corporate officer posts, he joined the board of directors of Select Medical Corporation in 2002 and was an independent director of that company for nearly a decade.

    Mr. Saich, who has held the post of co-president since 2023, will serve as the sole president of Select Medical.  He will retain oversight of outpatient rehabilitation and shared services operations while taking on expanded responsibilities across the organization.  Previously, Mr. Saich served as executive vice president and chief administrative officer from 2018-2023 and held a variety of senior human resources leadership positions spanning his 27 years with the company.

    Mr. Duggan, a 25-year Select Medical veteran, has been appointed executive vice president, general counsel and secretary after serving as executive vice president and deputy general counsel since 2023. Previously, Mr. Duggan held the posts of senior vice president and senior counsel from 2007-2023, vice president and senior counsel from 2002-2007, and associate counsel from 2000-2002.

    Michael E. Tarvin has served as senior executive vice president, general counsel and secretary since 2023, as executive vice president, general counsel and secretary from 2007-2023, as senior vice president, general counsel and secretary from 1999-2007, and as vice president, general counsel and secretary from 1997-1999.  Mr. Tarvin will transition to his new post as senior executive vice president of legal services.

    "Select Medical has always placed a high priority on the development and growth of its people as a means to drive the future success of the company," said Select Medical Co-Founder and Executive Chairman Robert A. Ortenzio.  "The appointments of these long-time veterans with impeccable track records underscores our commitment to our values, vision and mission.  I could not be more proud to see Select Medical's succession planning process working with the appointment of these next generation leaders, each with decades of experience at the company.  I look forward to continuing to work closely with these top-notch executives as we execute against an aggressive growth strategy that provides patients with access to world-class post-acute care across the country and delivers value to our stockholders."

    About Select Medical

    Select Medical is one of the largest operators of critical illness recovery hospitals, rehabilitation hospitals, and outpatient rehabilitation clinics in the United States based on number of facilities. As of June 30, 2025, Select Medical operated 104 critical illness recovery hospitals in 29 states, 36 rehabilitation hospitals in 14 states, and 1,919 outpatient rehabilitation clinics in 39 states and the District of Columbia. At June 30, 2025, Select Medical had operations in 40 states and the District of Columbia. Information about Select Medical is available at www.selectmedical.com.

    Media inquiries:

    Shelly Eckenroth

    [email protected]

    717-920-4035

    Investor inquiries:

    Joel T. Veit

    [email protected]

    717-972-1100

    Cision View original content:https://www.prnewswire.com/news-releases/select-medical-holdings-corporation-appoints-thomas-p-mullin-as-chief-executive-officer-and-announces-other-changes-involving-long-tenured-leaders-302542724.html

    SOURCE Select Medical Holdings Corporation

    Get the next $SEM alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $SEM

    DatePrice TargetRatingAnalyst
    10/8/2025$16.00 → $20.00Outperform
    RBC Capital Mkts
    4/16/2025$25.00Outperform
    Mizuho
    2/24/2025$23.00Hold → Buy
    The Benchmark Company
    11/25/2024Buy → Hold
    The Benchmark Company
    8/20/2024$42.00Buy
    BofA Securities
    3/7/2022$47.00 → $42.00Outperform
    RBC Capital
    1/18/2022$40.00 → $35.00Buy
    B of A Securities
    1/18/2022$50.00 → $47.00Outperform
    RBC Capital
    More analyst ratings

    $SEM
    SEC Filings

    View All

    SEC Form PRE 14A filed by Select Medical Holdings Corporation

    PRE 14A - SELECT MEDICAL HOLDINGS CORP (0001320414) (Filer)

    2/20/26 5:26:28 PM ET
    $SEM
    Hospital/Nursing Management
    Health Care

    SEC Form 10-K filed by Select Medical Holdings Corporation

    10-K - SELECT MEDICAL HOLDINGS CORP (0001320414) (Filer)

    2/19/26 4:48:28 PM ET
    $SEM
    Hospital/Nursing Management
    Health Care

    Select Medical Holdings Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Other Events, Financial Statements and Exhibits

    8-K - SELECT MEDICAL HOLDINGS CORP (0001320414) (Filer)

    2/19/26 4:41:45 PM ET
    $SEM
    Hospital/Nursing Management
    Health Care

    $SEM
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    RBC Capital Mkts reiterated coverage on Select Medical with a new price target

    RBC Capital Mkts reiterated coverage of Select Medical with a rating of Outperform and set a new price target of $20.00 from $16.00 previously

    10/8/25 10:00:36 AM ET
    $SEM
    Hospital/Nursing Management
    Health Care

    Mizuho initiated coverage on Select Medical with a new price target

    Mizuho initiated coverage of Select Medical with a rating of Outperform and set a new price target of $25.00

    4/16/25 9:09:30 AM ET
    $SEM
    Hospital/Nursing Management
    Health Care

    Select Medical upgraded by The Benchmark Company with a new price target

    The Benchmark Company upgraded Select Medical from Hold to Buy and set a new price target of $23.00

    2/24/25 7:15:26 AM ET
    $SEM
    Hospital/Nursing Management
    Health Care

    $SEM
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Frist William H. was granted 1,109 shares, increasing direct ownership by 0.36% to 305,172 units (SEC Form 4)

    4 - SELECT MEDICAL HOLDINGS CORP (0001320414) (Issuer)

    2/13/26 4:35:24 PM ET
    $SEM
    Hospital/Nursing Management
    Health Care

    New insider Hollenbach John Tyler claimed ownership of 135,084 shares (SEC Form 3)

    3 - SELECT MEDICAL HOLDINGS CORP (0001320414) (Issuer)

    1/6/26 5:33:42 PM ET
    $SEM
    Hospital/Nursing Management
    Health Care

    Executive Vice President Duggan John F. covered exercise/tax liability with 4,865 shares, decreasing direct ownership by 2% to 194,710 units (SEC Form 4)

    4 - SELECT MEDICAL HOLDINGS CORP (0001320414) (Issuer)

    11/4/25 5:58:19 PM ET
    $SEM
    Hospital/Nursing Management
    Health Care

    $SEM
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Khanuja Parvinderjit S. bought $315,420 worth of shares (21,000 units at $15.02), increasing direct ownership by 48% to 65,089 units (SEC Form 4)

    4 - SELECT MEDICAL HOLDINGS CORP (0001320414) (Issuer)

    5/6/25 6:21:53 PM ET
    $SEM
    Hospital/Nursing Management
    Health Care

    $SEM
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Select Medical Holdings Corporation Announces Results For Its Fourth Quarter and Year Ended December 31, 2025, Its 2026 Business Outlook, and Cash Dividend

    MECHANICSBURG, Pa., Feb. 19, 2026 /PRNewswire/ -- Select Medical Holdings Corporation ("Select Medical," "we," "us," or "our") (NYSE:SEM) today announced results for its fourth quarter and year ended December 31, 2025, its 2026 business outlook, and the declaration of a cash dividend. For the fourth quarter ended December 31, 2025, revenue increased 6.4% to $1,396.6 million, compared to $1,312.6 million for the same quarter, prior year. Income from continuing operations before other income and expense increased 203.1% to $63.9 million for the fourth quarter ended December 31, 2025, compared to $21.1 million for the same quarter, prior year. Income from continuing operations, net of tax, incr

    2/19/26 4:30:00 PM ET
    $SEM
    Hospital/Nursing Management
    Health Care

    PHILADELPHIA EAGLES RENEW DEAL WITH SELECT MEDICAL NAMING NOVACARE REHABILITATION THE TEAM'S OFFICIAL PHYSICAL THERAPY PARTNER

    MECHANICSBURG, Pa., Feb. 17, 2026 /PRNewswire/ -- Select Medical Corporation ("Select Medical") and the Philadelphia Eagles have announced a multi-year extension of its longstanding 25-year partnership naming NovaCare Rehabilitation as the team's Official Physical Therapy Partner. "We are proud to continue our longstanding founding partner relationship with the Philadelphia Eagles, an organization that shares our passion for excellence and creating unforgettable fan experiences," said Ray Pennacchia, senior vice president, NovaCare Rehabilitation. "Many of those fans also trust NovaCare Rehabilitation for world-class physical therapy throughout the Delaware Valley. This renewed agreement bui

    2/17/26 10:00:00 AM ET
    $SEM
    Hospital/Nursing Management
    Health Care

    Select Medical Holdings Corporation to Announce Fourth Quarter and Full Year 2025 Results and Business Outlook on Thursday, February 19, 2026

    MECHANICSBURG, Pa., Feb. 17, 2026 /PRNewswire/ -- Select Medical Holdings Corporation ("Select Medical") (NYSE:SEM), will release the financial results for its fourth quarter and full year ended December 31, 2025 on Thursday, February 19, 2026 after the market closes. Select Medical will host a conference call regarding its fourth quarter and full year results, as well as its business outlook, on Friday, February 20, 2026, at 9:00am ET. The conference call will be a live webcast and can be accessed via this Earnings Call Webcast Link or via link at Select Medical Holdings Corporation's website at www.selectmedicalholdings.com. A replay of the webcast will be available shortly after the call

    2/17/26 8:00:00 AM ET
    $SEM
    Hospital/Nursing Management
    Health Care

    $SEM
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Select Medical Holdings Corporation

    SC 13G/A - SELECT MEDICAL HOLDINGS CORP (0001320414) (Subject)

    11/14/24 1:22:35 PM ET
    $SEM
    Hospital/Nursing Management
    Health Care

    Amendment: SEC Form SC 13G/A filed by Select Medical Holdings Corporation

    SC 13G/A - SELECT MEDICAL HOLDINGS CORP (0001320414) (Subject)

    11/12/24 5:10:31 PM ET
    $SEM
    Hospital/Nursing Management
    Health Care

    Amendment: SEC Form SC 13G/A filed by Select Medical Holdings Corporation

    SC 13G/A - SELECT MEDICAL HOLDINGS CORP (0001320414) (Subject)

    11/12/24 5:10:04 PM ET
    $SEM
    Hospital/Nursing Management
    Health Care

    $SEM
    Leadership Updates

    Live Leadership Updates

    View All

    SELECT MEDICAL HOLDINGS CORPORATION APPOINTS THOMAS P. MULLIN AS CHIEF EXECUTIVE OFFICER AND ANNOUNCES OTHER CHANGES INVOLVING LONG-TENURED LEADERS

    MECHANICSBURG, Pa., Sept. 2, 2025 /PRNewswire/ -- Select Medical Holdings Corporation ("Select Medical") (NYSE:SEM) today announced the appointment of Thomas P. Mullin as its chief executive officer.  David S. Chernow, who has held the position since 2014, has been appointed vice chairman of the board.  John A. Saich, who most recently held the position of co-president, will serve as the company's sole president.  John F. Duggan has been appointed executive vice president, general counsel and secretary.  The appointments are effective immediately. Mr. Mullin joined Select Medical in 2008, most recently serving as co-president overseeing 140 critical illness recovery and inpatient rehabilita

    9/2/25 4:10:00 PM ET
    $SEM
    Hospital/Nursing Management
    Health Care

    Flex Set to Join S&P MidCap 400; Azenta and Concentra Group Holdings to Join S&P SmallCap 600

    NEW YORK, Nov. 19, 2024 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P MidCap 400 and S&P SmallCap 600: Flex Ltd (NASD: FLEX) will replace Azenta Inc. (NASD: AZTA) in the S&P MidCap 400, and Azenta will replace Envestnet Inc. (NYSE:ENV) in the S&P SmallCap 600 effective prior to the opening of trading on Monday, November 25. Bain Capital is acquiring Envestnet in a deal expected to be completed soon, pending final closing conditions. Azenta's market capitalization is no longer representative of the mid-cap market space.Concentra Group Holdings Inc. (NYSE:CON) will replace Myers Industries Inc. (NYSE:MYE) in the S&P SmallCap 600 effective prior to the openin

    11/19/24 5:56:00 PM ET
    $AZTA
    $CON
    $ENV
    Industrial Machinery/Components
    Technology
    Medical Specialities
    Health Care

    Select Medical Holdings Corporation Announces Appointment of Parvinderjit Singh Khanuja, M.D. to its Board of Directors

    MECHANICSBURG, Pa., Nov. 2, 2021 /PRNewswire/ -- Select Medical Holdings Corporation ("Select Medical") (NYSE:SEM) today announced the appointment of Parvinderjit Singh Khanuja, M.D. to its Board of Directors (the "Board"), effective on November 1, 2021.  Dr. Khanuja's Board term will expire at Select Medical's 2023 Annual Meeting of Stockholders, at which time he will stand for election along with the other director nominees standing for election at that meeting. "We are very pleased to welcome Dr. Khanuja to the Select Medical Board of Directors," said Robert A. Ortenzio, Executive Chairman and Co-Founder of Select Medical. "Dr. Khanuja brings to Select Medical over three decades of experi

    11/2/21 4:30:00 PM ET
    $SEM
    Hospital/Nursing Management
    Health Care

    $SEM
    Financials

    Live finance-specific insights

    View All

    Select Medical Holdings Corporation Announces Results For Its Fourth Quarter and Year Ended December 31, 2025, Its 2026 Business Outlook, and Cash Dividend

    MECHANICSBURG, Pa., Feb. 19, 2026 /PRNewswire/ -- Select Medical Holdings Corporation ("Select Medical," "we," "us," or "our") (NYSE:SEM) today announced results for its fourth quarter and year ended December 31, 2025, its 2026 business outlook, and the declaration of a cash dividend. For the fourth quarter ended December 31, 2025, revenue increased 6.4% to $1,396.6 million, compared to $1,312.6 million for the same quarter, prior year. Income from continuing operations before other income and expense increased 203.1% to $63.9 million for the fourth quarter ended December 31, 2025, compared to $21.1 million for the same quarter, prior year. Income from continuing operations, net of tax, incr

    2/19/26 4:30:00 PM ET
    $SEM
    Hospital/Nursing Management
    Health Care

    Select Medical Holdings Corporation to Announce Fourth Quarter and Full Year 2025 Results and Business Outlook on Thursday, February 19, 2026

    MECHANICSBURG, Pa., Feb. 17, 2026 /PRNewswire/ -- Select Medical Holdings Corporation ("Select Medical") (NYSE:SEM), will release the financial results for its fourth quarter and full year ended December 31, 2025 on Thursday, February 19, 2026 after the market closes. Select Medical will host a conference call regarding its fourth quarter and full year results, as well as its business outlook, on Friday, February 20, 2026, at 9:00am ET. The conference call will be a live webcast and can be accessed via this Earnings Call Webcast Link or via link at Select Medical Holdings Corporation's website at www.selectmedicalholdings.com. A replay of the webcast will be available shortly after the call

    2/17/26 8:00:00 AM ET
    $SEM
    Hospital/Nursing Management
    Health Care

    Select Medical Holdings Corporation to Announce Fourth Quarter and Full Year 2025 Results on Thursday, February 19, 2026

    MECHANICSBURG, Pa., Jan. 21, 2026 /PRNewswire/ -- Select Medical Holdings Corporation ("Select Medical") (NYSE:SEM), will release the financial results for its fourth quarter and full year ended December 31, 2025 on Thursday, February 19, 2026 after the market closes. Select Medical will host a conference call regarding its fourth quarter and full year results on Friday, February 20, 2026, at 9:00am ET. The conference call will be a live webcast and can be accessed via this Earnings Call Webcast Link or via link at Select Medical Holdings Corporation's website at www.selectmedicalholdings.com. A replay of the webcast will be available shortly after the call through the same link. For listen

    1/21/26 4:15:00 PM ET
    $SEM
    Hospital/Nursing Management
    Health Care